Written by Bill Fisher
Published: 11 August 2020
Wake Forest Baptist Health, in partnership with Javara, have announced they have begun recruiting healthy adults for a Phase 3 clinical research study to evaluate the safety and effectiveness of mRNA-1273, a vaccine candidate against COVID-19.
Sponsored by Moderna, the Study is recruiting healthy volunteers ages 18 or older in high-risk populations, including the elderly, racial and ethnic minorities at higher risk for COVID-19, and essential workers in close contact with potentially infected persons.
The Phase 3 study will evaluate if the vaccine boosts the immune system to produce enough antibodies against the virus that causes COVID-19, so it does not cause illness in case of infection.
Wake Forest Baptist Health and Javara are prioritizing candidates whose locations or circumstances put them at higher risk of exposure to the virus, including, the elderly, ages 65 and older, essential workers in close contact with potentially infected persons, including, but not limited to, healthcare and hospital workers, first responders, transit employees, institutional residents or workers, factory employees, and teachers and students, and racial and ethnic minorities at high risk for COVID-19.